… this preliminary study, we did not push the dosage level in these children beyond what would
be comparable to the standard oxybutynin … doses of extended-release oxybutynin could be …

… If patients whose initial daily dose of 10 mg of extended-release oxybutynin are not satisfied
with their improvement, they can increase the daily dose to 15, 20, 25, or even 30 mg, if …

… In a subgroup of 60 patients from this noncomparative study, switching to extended-release
oxybutynin from immediate-release oxybutynin or other anticholinergic drugs produced a …

… bladder, preventing contractions … 2 studies,*sJ6 the incidence of dry mouth was significantly
lower in patients treated with OROS oxybutynin compared with immediate-release oxybutynin…

… study was to conduct a preliminary evaluation of a new once-daily entericcoated
controlled-release (CR) oxybutynin … Taken oncedaily, controlled-release oxybutynin (Uromax*) …

… of this report is to describe the safety and tolerability of extended-release oxybutynin at a …
) and to compare the safety profile of extended-release oxybutynin 10 mg/day with that of …

… A further analysis of this study suggested that oxybutynin ER and tolterodine IR may be
similarly cost … initial dose of oxybutynin ER, with subsequent titration according to the response. …

… The pre- and post-dose serum oxybutynin and NDO concentrations were assessed at … ,
oxybutynin CR and conventional oxybutynin treatments did not differ in efficacy; the oxybutynin …

… A preliminary analysis of the first 103 patients from that study has recently been presented.[40]
According to this preliminary analysis, oxybutynin ER and tolterodine ER similarly …

… and safety of extended release (ER) oxybutynin at individualized doses for … studies of a total
of 420 patients with urge urinary incontinence or mixed incontinence in whom ER oxybutynin …